NMDA Receptor Antagonist and Use Thereof
US-2024254095-A1 · Aug 1, 2024 · US
condensed with one six-membered ring
condensed with one six-membered ring · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D267/14 |
| Official title | condensed with one six-membered ring |
| Display label | condensed with one six-membered ring |
| Total patents | 163 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 10 |
| 2016 | 13 |
| 2017 | 12 |
| 2018 | 12 |
| 2019 | 55 |
| 2020 | 15 |
| 2021 | 11 |
| 2022 | 9 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10501424-B2 · Dec 10, 2019 · US
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10428031-B2 · Oct 1, 2019 · US
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10421731-B2 · Sep 24, 2019 · US
Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
US-10287280-B2 · May 14, 2019 · US
NRF2 regulators
US-10272095-B2 · Apr 30, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119229-A1 · Apr 25, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119233-A1 · Apr 25, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119234-A1 · Apr 25, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119227-A1 · Apr 25, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119232-A1 · Apr 25, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119231-A1 · Apr 25, 2019 · US
Therapeutic compounds and uses thereof
US-10206931-B2 · Feb 19, 2019 · US
Alkylene derivatives
US-10150728-B2 · Dec 11, 2018 · US
Compounds, compositions and methods
US-10131676-B2 · Nov 20, 2018 · US
3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10112915-B2 · Oct 30, 2018 · US
Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (sstr4) agonists
US-2018291018-A1 · Oct 11, 2018 · US
Targeted notch pathway inhibitors
US-2018200262-A1 · Jul 19, 2018 · US
Nrf2 REGULATORS
US-2018179187-A1 · Jun 28, 2018 · US
Nrf2 REGULATORS
US-2018169110-A1 · Jun 21, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D267/14?
- CPC C07D267/14 is the Cooperative Patent Classification code for “condensed with one six-membered ring.”
- How many patents are filed under CPC C07D267/14 (condensed with one six-membered ring)?
- Our database includes 163 publications tagged with this CPC code.
- Is patent activity under CPC C07D267/14 growing?
- Publication counts under this code: 6 in 2024 vs 8 in 2025 (latest complete years).